FDA NDC Directory · JSON-LD · Markdown

Sitagliptin Phosphate

NDC 0781-5768 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerSandoz Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA202387
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsSITAGLIPTIN PHOSPHATE (50 mg/1)
Marketing started20260114
Package count2

External sources

Source: openFDA. Public-domain (CC0).